The zgc:153146 Antibody (Catalog ID: CSB-PA603902XA01DIL) is a polyclonal antibody developed for research applications targeting the UPF0602 protein C4orf47 homolog in zebrafish (Danio rerio). This antibody is part of a growing catalog of zebrafish-specific reagents for studying developmental biology, immunology, and disease modeling. Below is a detailed analysis of its characteristics, applications, and experimental findings, supported by available data.
Target Protein:
The antibody binds to the UPF0602 protein C4orf47 homolog (UniProt ID: Q0P4C5), which is annotated as a zebrafish ortholog of the human C4ORF47 gene. This protein belongs to the UPF0602 family, whose functions remain poorly characterized but are hypothesized to involve cellular signaling or developmental regulation .
Type: Polyclonal antibody (rabbit-derived).
Epitope: The antibody recognizes the N-terminal region of the target protein, as inferred from its catalog description .
The antibody is produced via immunization of rabbits with a synthetic peptide corresponding to the N-terminal residues of the zebrafish C4ORF47 protein. Key production details include:
Expression System: Recombinant protein expressed in yeast (for antigen preparation) .
Purification: Affinity chromatography (likely peptide-based) .
Purity: ≥90% as determined by SDS-PAGE and Western blotting .
Immunohistochemistry (IHC): Detects the target protein in zebrafish tissues .
ELISA: Quantitative analysis of C4ORF47 protein levels in lysates .
Developmental Biology: Studying embryonic patterning and organogenesis .
Disease Modeling: Investigating zebrafish models of human diseases linked to UPF0602 family proteins .
The C4ORF47 protein exhibits tissue-specific expression, with highest levels in larval stages, suggesting a role in early development .
KEGG: dre:751702
UniGene: Dr.92611
zgc:153146 Antibody (product code CSB-PA603902XA01DIL) is a polyclonal antibody that targets the protein encoded by the gene initially designated as zgc:153146, now identified by the gene symbol cfap96 (Entrez Gene ID: 751702). This antibody specifically recognizes the cfap96 protein in Danio rerio (zebrafish) . The target protein is cataloged in UniProt with the accession number Q0P4C5 . The antibody is raised in rabbits using recombinant Danio rerio zgc:153146 protein as the immunogen .
The zgc:153146 Antibody has been validated for two primary applications: Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These techniques allow researchers to detect and quantify the cfap96 protein in zebrafish samples. The antibody's specific reactivity to zebrafish makes it particularly valuable for developmental biology and comparative genomics research using this model organism .
For optimal performance and stability, zgc:153146 Antibody should be stored at either -20°C or -80°C . Proper aliquoting upon receipt is recommended to minimize freeze-thaw cycles. When working with the antibody, standard antibody handling protocols should be followed, including using sterile techniques and maintaining cold chain during experimental procedures. The antibody components include 0.2mg of purified antibody along with positive and negative controls for experimental validation .
The antibody product includes three components designed to facilitate experimental validation:
200μg of antigens that serve as a positive control
1ml of pre-immune serum that functions as a negative control
These controls are essential for establishing experimental baselines and validating assay specificity when working with this antibody.
For developmental biology research, zgc:153146 Antibody can be employed to track expression patterns of the cfap96 protein across different embryonic and larval stages of zebrafish. Researchers should consider the following methodological approach:
Sample collection at defined developmental timepoints (e.g., hours post fertilization)
Tissue preparation through either whole-mount protocols or sectioning
Immunohistochemistry or immunofluorescence optimization using the antibody at different dilutions
Co-localization studies with known developmental markers
The antibody's specificity to zebrafish makes it particularly valuable for studying the role of cfap96 in organ and tissue development, especially in comparative studies with other model organisms .
When designing co-immunoprecipitation (Co-IP) experiments with zgc:153146 Antibody, researchers should consider:
Optimization of lysis buffer composition to preserve protein-protein interactions while efficiently extracting the target protein
Pre-clearing lysates with the provided pre-immune serum to reduce non-specific binding
Titration of antibody amounts for optimal immunoprecipitation efficiency
Validation of results using the provided antigen as a positive control
Selection of appropriate beads (Protein A/G) based on the rabbit IgG isotype of this antibody
The polyclonal nature of this antibody may provide advantages in Co-IP by recognizing multiple epitopes, potentially improving capture efficiency of native protein complexes.
Advanced researchers can enhance experimental outcomes by applying antibody structure prediction principles to zgc:153146 Antibody applications. Recent advancements in computational methods have improved antibody loop structure prediction accuracy, which is critical for understanding epitope recognition . Researchers should:
Use available prediction tools to identify likely binding regions of the antibody to the cfap96 protein
Design experiments that account for potential structural changes in the target protein under different experimental conditions
Consider how experimental treatments might affect epitope accessibility
Implement epitope mapping strategies to confirm computational predictions
This approach aligns with modern antibody research methodologies where structural considerations significantly impact experimental outcomes and interpretation .
For complex tissue samples, validation of antibody specificity is crucial. Researchers should implement a multi-faceted validation approach:
Perform parallel experiments using the provided negative control (pre-immune serum)
Conduct peptide competition assays using the provided antigen
Include knockout/knockdown samples as negative controls where possible
Compare staining patterns with mRNA expression data from in situ hybridization
Validate across multiple detection techniques (WB, ELISA, IHC) to confirm consistent target recognition
These validation steps are particularly important when studying tissues with potential cross-reactive proteins or high background.
Based on available data and standard protocols for polyclonal antibodies, the following dilution ranges are recommended as starting points for optimization:
| Application | Recommended Initial Dilution Range | Optimization Strategy |
|---|---|---|
| Western Blot | 1:500 - 1:2000 | Titration series with consistent protein loading |
| ELISA | 1:1000 - 1:5000 | Standard curve with known antigen concentrations |
| Immunohistochemistry | 1:100 - 1:500 | Tissue-specific optimization with antigen retrieval variations |
| Immunofluorescence | 1:100 - 1:300 | Signal-to-noise ratio assessment with different fixation methods |
Each application requires specific optimization based on sample type, detection system, and experimental conditions .
When encountering non-specific binding, researchers should implement the following troubleshooting approach:
Increase blocking stringency using different blocking agents (BSA, normal serum, casein)
Optimize antibody concentration through careful titration experiments
Adjust incubation conditions (time, temperature, buffer composition)
Include additional washing steps with increased salt concentration or detergent
Utilize the provided pre-immune serum to identify and control for non-specific binding patterns
The polyclonal nature of this antibody means that some degree of background may be present, requiring careful optimization for each specific experimental context.
For quantitative applications such as protein expression analysis, researchers should implement:
Standard curve generation using the provided antigen at known concentrations
Selection of appropriate housekeeping proteins as internal controls
Technical replicates (minimum of three) to assess assay variability
Biological replicates to account for natural variation
Image analysis protocols with defined thresholds for signal quantification
For Western blot densitometry or ELISA absorbance readings, careful normalization procedures should be established to ensure reliable quantitative comparisons across samples .
In the context of integrative studies, zgc:153146 Antibody can serve as a valuable tool when combined with other research methodologies:
Correlation of protein detection (via this antibody) with transcriptomics data on cfap96 expression
Integration with proteomics datasets to confirm mass spectrometry identification
Combination with genetic manipulation (CRISPR, morpholinos) to study functional consequences
Application in ChIP-based approaches if studying protein-DNA interactions
This multi-platform integration provides more comprehensive insights into cfap96 function in zebrafish biology and development .
When applying this antibody in genetic models (knockdown, knockout, or overexpression):
Validate antibody specificity in the modified genetic background
Consider epitope availability in fusion proteins or truncated variants
Adjust detection protocols based on anticipated expression levels
Use the antibody to confirm genetic manipulation at the protein level
Compare experimental results with computational predictions of protein structure and antibody binding
These considerations are particularly important when the antibody is used to validate genetic modifications or to study the consequences of genetic manipulation on protein expression and localization .
The zgc:153146/cfap96 Antibody offers several advantages as a research tool:
Direct detection of the protein product rather than inference from mRNA
Species specificity for zebrafish models
Validation in multiple applications (ELISA, WB)
Availability of control materials for experimental validation
Emerging research areas that could leverage this antibody include:
Structural biology studies of cfap96 protein
Developmental regulation of cfap96 expression
Comparative studies across zebrafish strains or related species
Integration with advanced imaging techniques for protein localization
Application in protein-protein interaction networks relevant to cfap96 function